ClinicalTrials.gg
CompletedNCT07922811Updated Nov 6, 2026

Submaximal Versus Maximal Isometric Tongue Training After Stroke

An interventional study of Isometric tongue resistance training at 80% 1RM and Isometric tongue resistance training at 100% 1RM in Stroke and Deglutition Disorder, sponsored by Necmettin Erbakan University. Completed at 2 sites in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Necmettin Erbakan University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 9 months after the study started (first participant enrolled Jan 2024, registered Nov 2026).
Updated Nov 6, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial was to learn whether the intensity of tongue-strengthening exercise affects tongue strength and swallowing in adults who have swallowing difficulty (dysphagia) 1 to 12 months after a stroke. The main questions it aimed to answer were:

  • Does training at 80% or 100% of a person's maximum tongue pressure increase tongue strength more than usual care?
  • Does training at 100% of maximum tongue pressure increase tongue strength more than training at 80%?
  • Does either training intensity improve swallowing safety, throat residue after swallowing, the ability to eat by mouth, or swallowing-related quality of life?

Researchers compared the two exercise groups with a usual-care group that did not receive structured exercise.

Participants in the exercise groups pressed their tongue against an air-filled bulb (Iowa Oral Performance Instrument) three times a week for six weeks, with the target pressure updated every week. All participants had their tongue strength, tongue endurance and swallowing (by endoscopic swallowing examination) assessed before and after the six weeks. Participants in the exercise groups were assessed again four weeks later.

Read the detailed description

This three-arm pilot randomised controlled trial was conducted at two otorhinolaryngology outpatient clinics in Türkiye as part of a doctoral thesis funded by TÜBİTAK. Participants were randomised, stratified by age (41-60 and >60 years), to isometric lingual resistance training at 80% of the one-repetition maximum (1RM), training at 100% 1RM, or usual care. Training consisted of anterior and posterior tongue presses with the Iowa Oral Performance Instrument (5 sets × 10 repetitions per region, 2-s holds), three sessions per week for six weeks, with 1RM re-measured weekly. Outcome assessors were not informed of group allocation. Assessments were performed at baseline, at six weeks and, in the training groups, four weeks after the intervention.

02

Conditions studied

  • Stroke
  • Deglutition Disorder

Keywords

  • Tongue Strength
  • Isometric Exercise
  • Resistance Training
  • Iowa Oral Performance Instrument
03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's enrollment of 38 is below the median of 49 across 6,024 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Necmettin Erbakan University is the lead sponsor of 201 studies on the registry; 48 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Diagnosis of ischaemic or haemorrhagic stroke according to ICD-10
  • 1 to 12 months since stroke onset
  • score of 21 or higher
  • Score of 94 or lower on the Turkish version of the Modified Mann Assessment of Swallowing Ability (TR-MMASA)
  • Posterior maximum isometric tongue pressure below 40 kPa

Exclusion criteria

Exclusion Criteria:

  • History of head and neck cancer or radiotherapy to the head and neck
  • Diagnosed neurodegenerative disease
  • Diagnosed cognitive or psychiatric disorder
  • History of cardiomyopathy, congestive heart failure or myocardial infarction
  • History of pulmonary embolism or deep vein thrombosis
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
38 participants (actual)

Study arms

  • Experimental
    80% 1RM Isometric Tongue Training

    Isometric tongue resistance training with the Iowa Oral Performance Instrument at 80% of the one-repetition maximum (1RM), three sessions per week for six weeks. Each session comprised anterior and posterior tongue presses, 5 sets × 10 repetitions per region, 2-s holds, 10-s rest between repetitions and 1-min rest between sets. 1RM was re-measured at the start of each week and the target pressure updated.

    Behavioral: Isometric tongue resistance training at 80% 1RM

  • Experimental
    100% 1RM Isometric Tongue Training

    Isometric tongue resistance training with the Iowa Oral Performance Instrument at 100% of the one-repetition maximum (1RM), with a maximal effort on every repetition, three sessions per week for six weeks. Session structure, rest intervals and weekly 1RM re-measurement were identical to the 80% 1RM arm.

    Behavioral: Isometric tongue resistance training at 100% 1RM

  • No intervention
    Usual Care

    Routine clinical follow-up without structured tongue exercise during the six-week study period. The training protocol was offered to participants after data collection.

Interventions

  • BehavioralIsometric tongue resistance training at 80% 1RM

    Iowa Oral Performance Instrument-guided isometric tongue presses against the hard palate at the anterior and posterior tongue, at 80% of the weekly re-measured one-repetition maximum, with visual feedback; 5 sets × 10 repetitions per region, 2-s holds, three sessions per week for six weeks.

  • BehavioralIsometric tongue resistance training at 100% 1RM

    Iowa Oral Performance Instrument-guided isometric tongue presses against the hard palate at the anterior and posterior tongue, with a maximal effort (100% of the weekly re-measured one-repetition maximum) on every repetition; 5 sets × 10 repetitions per region, 2-s holds, three sessions per week for six weeks.

06

What researchers measure

Primary outcomes

  1. Posterior maximum isometric tongue pressure

    Highest of three maximal tongue-to-palate presses at the posterior tongue (10 mm anterior to the circumvallate papillae), measured in kilopascals (kPa) with the Iowa Oral Performance Instrument.

    Time frame: Baseline and 6 weeks

Secondary outcomes

  1. Anterior maximum isometric tongue pressure

    Highest of three maximal tongue-to-palate presses at the anterior tongue (10 mm posterior to the tongue tip), measured in kPa with the Iowa Oral Performance Instrument.

    Time frame: Baseline and 6 weeks

  2. Anterior tongue endurance

    Longest time (seconds) for which participants sustained 50% of the anterior maximum pressure obtained in the same session, measured with the Iowa Oral Performance Instrument.

    Time frame: Baseline and 6 weeks

  3. Posterior tongue endurance

    Longest time (seconds) for which participants sustained 50% of the posterior maximum pressure obtained in the same session, measured with the Iowa Oral Performance Instrument.

    Time frame: Baseline and 6 weeks

  4. Penetration-Aspiration Scale score, puree

    Airway protection during a 10-mL IDDSI Level 3 (puree) bolus on fibreoptic endoscopic evaluation of swallowing; 8-point scale from 1 (no airway entry) to 8 (silent aspiration); lower scores are better.

    Time frame: Baseline and 6 weeks

  5. Penetration-Aspiration Scale score, thin liquid

    Airway protection during a 10-mL IDDSI Level 0 (thin liquid) bolus on fibreoptic endoscopic evaluation of swallowing; 8-point scale from 1 to 8; lower scores are better.

    Time frame: Baseline and 6 weeks

  6. Vallecular residue (Yale Pharyngeal Residue Severity Rating Scale)

    Residue in the valleculae after a puree bolus on fibreoptic endoscopic evaluation of swallowing; 5-point scale from 1 (none) to 5 (severe); lower scores are better.

    Time frame: Baseline and 6 weeks

  7. Pyriform sinus residue (Yale Pharyngeal Residue Severity Rating Scale)

    Residue in the pyriform sinuses after a puree bolus on fibreoptic endoscopic evaluation of swallowing; 5-point scale from 1 (none) to 5 (severe); lower scores are better.

    Time frame: Baseline and 6 weeks

  8. Functional Oral Intake Scale

    Level of oral intake on a 7-point scale from 1 (nothing by mouth) to 7 (total oral diet without restrictions); higher scores are better.

    Time frame: Baseline and 6 weeks

  9. Swallowing-related quality of life (T-SWAL-QOL)

    Total score on the Turkish version of the Swallowing Quality of Life Questionnaire; higher scores indicate better swallowing-related quality of life.

    Time frame: Baseline and 6 weeks

Other outcomes

  1. Tongue pressure at follow-up

    Anterior and posterior maximum isometric tongue pressure (kPa), Iowa Oral Performance Instrument; assessed in the two training arms only.

    Time frame: 10 weeks (4 weeks after the end of training)

  2. Tongue endurance at follow-up

    Anterior and posterior tongue endurance (seconds) at 50% of the same-session maximum, Iowa Oral Performance Instrument; assessed in the two training arms only.

    Time frame: 10 weeks (4 weeks after the end of training)

07

Study locations

2 sites
  • Kayseri City Education and Research Hospital
    Kayseri, 38080, Turkey (Türkiye)
  • Selçuk University Faculty of Medicine Hospital
    Konya, 42130, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying the results reported in the article (tongue pressure, tongue endurance, PAS, YPRSS, FOIS and T-SWAL-QOL at all time points, together with age stratum, sex and stroke characteristics) will be shared.

Supporting information: Study protocol, Statistical analysis plan, Analytic code

Time frame: Beginning at publication of the main article and for at least 5 years thereafter.

Access criteria: Data will be available to researchers who provide a methodologically sound proposal, upon reasonable request to the corresponding author (fzt.s.kocaoglu@gmail.com). A data-sharing agreement may be required.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2024 to primary completion in Mar 2025, 13 months.

Of 3,108 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 13 months is below that.

Counting every sponsor, half of 3,252 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 2, 2026
First posted
Nov 6, 2026
StartActual
Jan 3, 2024
Primary completionActual
Mar 1, 2025
CompletionActual
Apr 1, 2025
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07922811
Collaborators
The Scientific and Technological Research Council of Turkey, Anadolu University
Responsible party
Süleyman Kocaoğlu (Assistant Professor, Necmettin Erbakan University) — Principal investigator
First posted
Nov 6, 2026
Start date
Jan 3, 2024
Primary completion
Mar 1, 2025
Completion
Apr 1, 2025
Last update
Nov 6, 2026

Study contacts

Süleyman Kocaoğlu
principal investigator · Necmettin Erbakan University
Nurdan cankuvvet
study director · Anadolu University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion